MS: Busting the Myths
February 24, 2025 | Advocacy, News
Recently, Multiple Sclerosis New Zealand (MSNZ) wrote to Pharmac to express our immense disappointment with their Health Technologies Assessment (HTA) process, the treatment funding assessment process, and the impact this is having on the MS community. The varicella zoster virus, […]
February 11, 2025 | News
Pharmac is drafting a comprehensive list of hospital medical devices currently used by Health New Zealand hospitals. They are consulting to make sure this comprehensive list is accurate and complete with the aim of ensuring all hospitals in New Zealand […]
October 15, 2024 | Media, News, Press Release, Progressive
Pharmac’s decision-making process for funding drugs in Aotearoa New Zealand is in need of a major overhaul – according to a new independent report. The Milne Report, commissioned by Multiple Sclerosis New Zealand (MSNZ), says its time Pharmac based its […]
May 30, 2024 | Advocacy, Treatments
At MSNZ we would like to understand more about patient experiences with infusion treatments. The first line Disease Modifying Treatment (DMT) options we have been successful in advocating for in NZ are considered some of the best in the world. […]
February 29, 2024 | Advocacy
Multiple Sclerosis NZ is a proud member of the Neurological Alliance along with 19 other allied organisations. The Neurological Alliance of New Zealand (the Alliance) was established in 1999 to provide a forum for organisations representing a neurological disease to: […]